Cargando…
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196101/ https://www.ncbi.nlm.nih.gov/pubmed/34131632 http://dx.doi.org/10.1097/HS9.0000000000000592 |
| _version_ | 1783706622905810944 |
|---|---|
| author | Clerico, Michele Dogliotti, Irene Calcagno, Andrea Grimaldi, Daniele Leone, Sarah Ragaini, Simone Boffini, Massimo Caracciolo, Daniele Ferrero, Simone Barbero, Cristina Zanotto, Elisa Stroffolini, Giacomo Cavallo, Rossana Rinaldi, Mauro Bruno, Benedetto Cavallo, Federica |
| author_facet | Clerico, Michele Dogliotti, Irene Calcagno, Andrea Grimaldi, Daniele Leone, Sarah Ragaini, Simone Boffini, Massimo Caracciolo, Daniele Ferrero, Simone Barbero, Cristina Zanotto, Elisa Stroffolini, Giacomo Cavallo, Rossana Rinaldi, Mauro Bruno, Benedetto Cavallo, Federica |
| author_sort | Clerico, Michele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8196101 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81961012021-06-14 COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment Clerico, Michele Dogliotti, Irene Calcagno, Andrea Grimaldi, Daniele Leone, Sarah Ragaini, Simone Boffini, Massimo Caracciolo, Daniele Ferrero, Simone Barbero, Cristina Zanotto, Elisa Stroffolini, Giacomo Cavallo, Rossana Rinaldi, Mauro Bruno, Benedetto Cavallo, Federica Hemasphere Case Report Lippincott Williams & Wilkins 2021-06-12 /pmc/articles/PMC8196101/ /pubmed/34131632 http://dx.doi.org/10.1097/HS9.0000000000000592 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (https://creativecommons.org/licenses/by-nc-sa/4.0/) , which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Case Report Clerico, Michele Dogliotti, Irene Calcagno, Andrea Grimaldi, Daniele Leone, Sarah Ragaini, Simone Boffini, Massimo Caracciolo, Daniele Ferrero, Simone Barbero, Cristina Zanotto, Elisa Stroffolini, Giacomo Cavallo, Rossana Rinaldi, Mauro Bruno, Benedetto Cavallo, Federica COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title | COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title_full | COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title_fullStr | COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title_full_unstemmed | COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title_short | COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment |
| title_sort | covid-19 in a post-transplant heart recipient who developed aggressive lymphoma: a biphasic course during rituximab treatment |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196101/ https://www.ncbi.nlm.nih.gov/pubmed/34131632 http://dx.doi.org/10.1097/HS9.0000000000000592 |
| work_keys_str_mv | AT clericomichele covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT dogliottiirene covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT calcagnoandrea covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT grimaldidaniele covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT leonesarah covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT ragainisimone covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT boffinimassimo covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT caracciolodaniele covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT ferrerosimone covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT barberocristina covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT zanottoelisa covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT stroffolinigiacomo covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT cavallorossana covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT rinaldimauro covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT brunobenedetto covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment AT cavallofederica covid19inaposttransplantheartrecipientwhodevelopedaggressivelymphomaabiphasiccourseduringrituximabtreatment |